Chemistry:Ridazolol
From HandWiki
Names | |
---|---|
IUPAC name
5-Chloro-4-[2-[[3-(2-chlorophenoxy)-2-hydroxypropyl]amino]ethylamino]-1H-pyridazin-6-one
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C15H18Cl2N4O3 | |
Molar mass | 373.23 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Tracking categories (test):
Ridazolol is a pharmaceutical drug acting as a beta adrenergic receptor antagonist. It was investigated in the 1980 and 90s for its effects on coronary heart disease and essential hypertension (high blood pressure).[1][2]
It is not known to be marketed anywhere in the world.[3]
References
- ↑ Fach, WA; Starke, E; Becker, HJ (1992). "Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease". Zeitschrift für Kardiologie 81 (6): 320–5. PMID 1353933.
- ↑ Rommel, Th.; Demisch, L. (1994). "Influence of chronic ?-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension". Journal of Neural Transmission 95 (1): 39–48. doi:10.1007/BF01283029. PMID 7857585.
- ↑ "Ridazolol search results". Drugs.com. https://www.drugs.com/search.php?searchterm=ridazolol. Retrieved 2021-03-31.
Original source: https://en.wikipedia.org/wiki/Ridazolol.
Read more |